世界のエノキサパリンナトリウム注射市場インサイト・予測（～2027年）

• 英文タイトル：Global Enoxaparin Sodium Injection Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4057 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はエノキサパリンナトリウム注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。エノキサパリンナトリウム注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（20 mg/0.2mL、30 mg/0.3mL、40 mg/0.4mL、60 mg/0.6mL、80 mg/0.8mL、100 mg/1mL、120 mg/0.8mL、150 mg/1mL、300mg/3mL）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・エノキサパリンナトリウム注射の世界市場概要 ・メーカー別の競争状況、市場シェア ・エノキサパリンナトリウム注射の種類別市場規模：20 mg/0.2mL、30 mg/0.3mL、40 mg/0.4mL、60 mg/0.6mL、80 mg/0.8mL、100 mg/1mL、120 mg/0.8mL、150 mg/1mL、300mg/3mL ・エノキサパリンナトリウム注射の用途別市場規模：病院、クリニック、その他 ・北米のエノキサパリンナトリウム注射市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのエノキサパリンナトリウム注射市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのエノキサパリンナトリウム注射市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のエノキサパリンナトリウム注射市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのエノキサパリンナトリウム注射市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Sanofi、Fresenius Kabi、Rovi、Amphastar、Teva、Nanjing King-friend、Techdow (Hepalink)、Sandoz、Apotex、Cipla、Taj Pharma、Hangzhou Jiuyuan Gene Engineering、Chengdu Baiyu Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Changzhou Qianhong Bio-pharma、Beijing SL Pharmaceutical、Suzhou Erye Pharmaceutical ・エノキサパリンナトリウム注射のバリューチェーン・販売チャネル分析 ・エノキサパリンナトリウム注射の世界市場動向

Market Analysis and Insights: Global Enoxaparin Sodium Injection Market
The global Enoxaparin Sodium Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Enoxaparin Sodium Injection Scope and Segment
Enoxaparin Sodium Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Enoxaparin Sodium Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL

Segment by Application
Hospital
Clinic
Others

By Company
Sanofi
Fresenius Kabi
Rovi
Amphastar
Teva
Nanjing King-friend
Techdow (Hepalink)
Sandoz
Apotex
Cipla
Taj Pharma
Hangzhou Jiuyuan Gene Engineering
Chengdu Baiyu Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Suzhou Erye Pharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Enoxaparin Sodium Injection Product Introduction
1.2 Market by Type
1.2.1 Global Enoxaparin Sodium Injection Market Size Growth Rate by Type
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Market by Application
1.3.1 Global Enoxaparin Sodium Injection Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Enoxaparin Sodium Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Enoxaparin Sodium Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Enoxaparin Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Enoxaparin Sodium Injection Regions by Sales
2.4.1 Global Top Enoxaparin Sodium Injection Regions by Sales (2016-2021)
2.4.2 Global Top Enoxaparin Sodium Injection Regions by Sales (2022-2027)
2.5 Global Top Enoxaparin Sodium Injection Regions by Revenue
2.5.1 Global Top Enoxaparin Sodium Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Enoxaparin Sodium Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Enoxaparin Sodium Injection Sales by Manufacturers
3.1.1 Global Top Enoxaparin Sodium Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Enoxaparin Sodium Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Enoxaparin Sodium Injection Sales in 2020
3.2 Global Enoxaparin Sodium Injection Revenue by Manufacturers
3.2.1 Global Top Enoxaparin Sodium Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Enoxaparin Sodium Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Enoxaparin Sodium Injection Revenue in 2020
3.3 Global Enoxaparin Sodium Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Enoxaparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Enoxaparin Sodium Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Enoxaparin Sodium Injection Sales by Type
4.1.1 Global Enoxaparin Sodium Injection Historical Sales by Type (2016-2021)
4.1.2 Global Enoxaparin Sodium Injection Forecasted Sales by Type (2022-2027)
4.1.3 Global Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
4.2 Global Enoxaparin Sodium Injection Revenue by Type
4.2.1 Global Enoxaparin Sodium Injection Historical Revenue by Type (2016-2021)
4.2.2 Global Enoxaparin Sodium Injection Forecasted Revenue by Type (2022-2027)
4.2.3 Global Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
4.3 Global Enoxaparin Sodium Injection Price by Type
4.3.1 Global Enoxaparin Sodium Injection Price by Type (2016-2021)
4.3.2 Global Enoxaparin Sodium Injection Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Enoxaparin Sodium Injection Sales by Application
5.1.1 Global Enoxaparin Sodium Injection Historical Sales by Application (2016-2021)
5.1.2 Global Enoxaparin Sodium Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
5.2 Global Enoxaparin Sodium Injection Revenue by Application
5.2.1 Global Enoxaparin Sodium Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Enoxaparin Sodium Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
5.3 Global Enoxaparin Sodium Injection Price by Application
5.3.1 Global Enoxaparin Sodium Injection Price by Application (2016-2021)
5.3.2 Global Enoxaparin Sodium Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Enoxaparin Sodium Injection Market Size by Type
6.1.1 North America Enoxaparin Sodium Injection Sales by Type (2016-2027)
6.1.2 North America Enoxaparin Sodium Injection Revenue by Type (2016-2027)
6.2 North America Enoxaparin Sodium Injection Market Size by Application
6.2.1 North America Enoxaparin Sodium Injection Sales by Application (2016-2027)
6.2.2 North America Enoxaparin Sodium Injection Revenue by Application (2016-2027)
6.3 North America Enoxaparin Sodium Injection Market Size by Country
6.3.1 North America Enoxaparin Sodium Injection Sales by Country (2016-2027)
6.3.2 North America Enoxaparin Sodium Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Enoxaparin Sodium Injection Market Size by Type
7.1.1 Europe Enoxaparin Sodium Injection Sales by Type (2016-2027)
7.1.2 Europe Enoxaparin Sodium Injection Revenue by Type (2016-2027)
7.2 Europe Enoxaparin Sodium Injection Market Size by Application
7.2.1 Europe Enoxaparin Sodium Injection Sales by Application (2016-2027)
7.2.2 Europe Enoxaparin Sodium Injection Revenue by Application (2016-2027)
7.3 Europe Enoxaparin Sodium Injection Market Size by Country
7.3.1 Europe Enoxaparin Sodium Injection Sales by Country (2016-2027)
7.3.2 Europe Enoxaparin Sodium Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Enoxaparin Sodium Injection Market Size by Type
8.1.1 Asia Pacific Enoxaparin Sodium Injection Sales by Type (2016-2027)
8.1.2 Asia Pacific Enoxaparin Sodium Injection Revenue by Type (2016-2027)
8.2 Asia Pacific Enoxaparin Sodium Injection Market Size by Application
8.2.1 Asia Pacific Enoxaparin Sodium Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Enoxaparin Sodium Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Enoxaparin Sodium Injection Market Size by Region
8.3.1 Asia Pacific Enoxaparin Sodium Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Enoxaparin Sodium Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Enoxaparin Sodium Injection Market Size by Type
9.1.1 Latin America Enoxaparin Sodium Injection Sales by Type (2016-2027)
9.1.2 Latin America Enoxaparin Sodium Injection Revenue by Type (2016-2027)
9.2 Latin America Enoxaparin Sodium Injection Market Size by Application
9.2.1 Latin America Enoxaparin Sodium Injection Sales by Application (2016-2027)
9.2.2 Latin America Enoxaparin Sodium Injection Revenue by Application (2016-2027)
9.3 Latin America Enoxaparin Sodium Injection Market Size by Country
9.3.1 Latin America Enoxaparin Sodium Injection Sales by Country (2016-2027)
9.3.2 Latin America Enoxaparin Sodium Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Enoxaparin Sodium Injection Market Size by Type
10.1.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Type (2016-2027)
10.1.2 Middle East and Africa Enoxaparin Sodium Injection Revenue by Type (2016-2027)
10.2 Middle East and Africa Enoxaparin Sodium Injection Market Size by Application
10.2.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Enoxaparin Sodium Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Enoxaparin Sodium Injection Market Size by Country
10.3.1 Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Enoxaparin Sodium Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Sanofi Enoxaparin Sodium Injection Product Description
11.1.5 Sanofi Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Overview
11.2.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Fresenius Kabi Enoxaparin Sodium Injection Product Description
11.2.5 Fresenius Kabi Recent Developments
11.3 Rovi
11.3.1 Rovi Corporation Information
11.3.2 Rovi Overview
11.3.3 Rovi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Rovi Enoxaparin Sodium Injection Product Description
11.3.5 Rovi Recent Developments
11.4 Amphastar
11.4.1 Amphastar Corporation Information
11.4.2 Amphastar Overview
11.4.3 Amphastar Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Amphastar Enoxaparin Sodium Injection Product Description
11.4.5 Amphastar Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Teva Enoxaparin Sodium Injection Product Description
11.5.5 Teva Recent Developments
11.6 Nanjing King-friend
11.6.1 Nanjing King-friend Corporation Information
11.6.2 Nanjing King-friend Overview
11.6.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Nanjing King-friend Enoxaparin Sodium Injection Product Description
11.6.5 Nanjing King-friend Recent Developments
11.7 Techdow (Hepalink)
11.7.1 Techdow (Hepalink) Corporation Information
11.7.2 Techdow (Hepalink) Overview
11.7.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Description
11.7.5 Techdow (Hepalink) Recent Developments
11.8 Sandoz
11.8.1 Sandoz Corporation Information
11.8.2 Sandoz Overview
11.8.3 Sandoz Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sandoz Enoxaparin Sodium Injection Product Description
11.8.5 Sandoz Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Apotex Enoxaparin Sodium Injection Product Description
11.9.5 Apotex Recent Developments
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Overview
11.10.3 Cipla Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Cipla Enoxaparin Sodium Injection Product Description
11.10.5 Cipla Recent Developments
11.11 Taj Pharma
11.11.1 Taj Pharma Corporation Information
11.11.2 Taj Pharma Overview
11.11.3 Taj Pharma Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Taj Pharma Enoxaparin Sodium Injection Product Description
11.11.5 Taj Pharma Recent Developments
11.12 Hangzhou Jiuyuan Gene Engineering
11.12.1 Hangzhou Jiuyuan Gene Engineering Corporation Information
11.12.2 Hangzhou Jiuyuan Gene Engineering Overview
11.12.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Description
11.12.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
11.13 Chengdu Baiyu Pharmaceutical
11.13.1 Chengdu Baiyu Pharmaceutical Corporation Information
11.13.2 Chengdu Baiyu Pharmaceutical Overview
11.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Description
11.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
11.14 Hebei Changshan Biochemical Pharmaceutical
11.14.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
11.14.2 Hebei Changshan Biochemical Pharmaceutical Overview
11.14.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Description
11.14.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
11.15 Changzhou Qianhong Bio-pharma
11.15.1 Changzhou Qianhong Bio-pharma Corporation Information
11.15.2 Changzhou Qianhong Bio-pharma Overview
11.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Description
11.15.5 Changzhou Qianhong Bio-pharma Recent Developments
11.16 Beijing SL Pharmaceutical
11.16.1 Beijing SL Pharmaceutical Corporation Information
11.16.2 Beijing SL Pharmaceutical Overview
11.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Description
11.16.5 Beijing SL Pharmaceutical Recent Developments
11.17 Suzhou Erye Pharmaceutical
11.17.1 Suzhou Erye Pharmaceutical Corporation Information
11.17.2 Suzhou Erye Pharmaceutical Overview
11.17.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Description
11.17.5 Suzhou Erye Pharmaceutical Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Enoxaparin Sodium Injection Value Chain Analysis
12.2 Enoxaparin Sodium Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Enoxaparin Sodium Injection Production Mode & Process
12.4 Enoxaparin Sodium Injection Sales and Marketing
12.4.1 Enoxaparin Sodium Injection Sales Channels
12.4.2 Enoxaparin Sodium Injection Distributors
12.5 Enoxaparin Sodium Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Enoxaparin Sodium Injection Industry Trends
13.2 Enoxaparin Sodium Injection Market Drivers
13.3 Enoxaparin Sodium Injection Market Challenges
13.4 Enoxaparin Sodium Injection Market Restraints

14 Key Findings in The Global Enoxaparin Sodium Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Enoxaparin Sodium Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 20 mg/0.2mL
Table 3. Major Manufacturers of 30 mg/0.3mL
Table 4. Major Manufacturers of 40 mg/0.4mL
Table 5. Major Manufacturers of 60 mg/0.6mL
Table 6. Major Manufacturers of 80 mg/0.8mL
Table 7. Major Manufacturers of 100 mg/1mL
Table 8. Major Manufacturers of 120 mg/0.8mL
Table 9. Major Manufacturers of 150 mg/1mL
Table 10. Major Manufacturers of 300mg/3mL
Table 11. Global Enoxaparin Sodium Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 12. Global Enoxaparin Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 13. Global Enoxaparin Sodium Injection Sales by Region (2016-2021) & (K Units)
Table 14. Global Enoxaparin Sodium Injection Sales Market Share by Region (2016-2021)
Table 15. Global Enoxaparin Sodium Injection Sales by Region (2022-2027) & (K Units)
Table 16. Global Enoxaparin Sodium Injection Sales Market Share by Region (2022-2027)
Table 17. Global Enoxaparin Sodium Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2016-2021)
Table 19. Global Enoxaparin Sodium Injection Revenue by Region (2022-2027) & (US$ Million)
Table 20. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2022-2027)
Table 21. Global Enoxaparin Sodium Injection Sales by Manufacturers (2016-2021) & (K Units)
Table 22. Global Enoxaparin Sodium Injection Sales Share by Manufacturers (2016-2021)
Table 23. Global Enoxaparin Sodium Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 24. Global Enoxaparin Sodium Injection Revenue Share by Manufacturers (2016-2021)
Table 25. Enoxaparin Sodium Injection Price by Manufacturers 2016-2021 (US$/Unit)
Table 26. Global Enoxaparin Sodium Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Enoxaparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium Injection as of 2020)
Table 28. Enoxaparin Sodium Injection Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Enoxaparin Sodium Injection Product Offered
Table 30. Date of Manufacturers Enter into Enoxaparin Sodium Injection Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Enoxaparin Sodium Injection Sales by Type (2016-2021) & (K Units)
Table 33. Global Enoxaparin Sodium Injection Sales by Type (2022-2027) & (K Units)
Table 34. Global Enoxaparin Sodium Injection Sales Share by Type (2016-2021)
Table 35. Global Enoxaparin Sodium Injection Sales Share by Type (2022-2027)
Table 36. Global Enoxaparin Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 37. Global Enoxaparin Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 38. Global Enoxaparin Sodium Injection Revenue Share by Type (2016-2021)
Table 39. Global Enoxaparin Sodium Injection Revenue Share by Type (2022-2027)
Table 40. Enoxaparin Sodium Injection Price by Type (2016-2021) & (US$/Unit)
Table 41. Global Enoxaparin Sodium Injection Price Forecast by Type (2022-2027) & (US$/Unit)
Table 42. Global Enoxaparin Sodium Injection Sales by Application (2016-2021) & (K Units)
Table 43. Global Enoxaparin Sodium Injection Sales by Application (2022-2027) & (K Units)
Table 44. Global Enoxaparin Sodium Injection Sales Share by Application (2016-2021)
Table 45. Global Enoxaparin Sodium Injection Sales Share by Application (2022-2027)
Table 46. Global Enoxaparin Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 47. Global Enoxaparin Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 48. Global Enoxaparin Sodium Injection Revenue Share by Application (2016-2021)
Table 49. Global Enoxaparin Sodium Injection Revenue Share by Application (2022-2027)
Table 50. Enoxaparin Sodium Injection Price by Application (2016-2021) & (US$/Unit)
Table 51. Global Enoxaparin Sodium Injection Price Forecast by Application (2022-2027) & (US$/Unit)
Table 52. North America Enoxaparin Sodium Injection Sales by Type (2016-2021) & (K Units)
Table 53. North America Enoxaparin Sodium Injection Sales by Type (2022-2027) & (K Units)
Table 54. North America Enoxaparin Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 55. North America Enoxaparin Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 56. North America Enoxaparin Sodium Injection Sales by Application (2016-2021) & (K Units)
Table 57. North America Enoxaparin Sodium Injection Sales by Application (2022-2027) & (K Units)
Table 58. North America Enoxaparin Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 59. North America Enoxaparin Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 60. North America Enoxaparin Sodium Injection Sales by Country (2016-2021) & (K Units)
Table 61. North America Enoxaparin Sodium Injection Sales by Country (2022-2027) & (K Units)
Table 62. North America Enoxaparin Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 63. North America Enoxaparin Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 64. Europe Enoxaparin Sodium Injection Sales by Type (2016-2021) & (K Units)
Table 65. Europe Enoxaparin Sodium Injection Sales by Type (2022-2027) & (K Units)
Table 66. Europe Enoxaparin Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 67. Europe Enoxaparin Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 68. Europe Enoxaparin Sodium Injection Sales by Application (2016-2021) & (K Units)
Table 69. Europe Enoxaparin Sodium Injection Sales by Application (2022-2027) & (K Units)
Table 70. Europe Enoxaparin Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 71. Europe Enoxaparin Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 72. Europe Enoxaparin Sodium Injection Sales by Country (2016-2021) & (K Units)
Table 73. Europe Enoxaparin Sodium Injection Sales by Country (2022-2027) & (K Units)
Table 74. Europe Enoxaparin Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 75. Europe Enoxaparin Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 76. Asia Pacific Enoxaparin Sodium Injection Sales by Type (2016-2021) & (K Units)
Table 77. Asia Pacific Enoxaparin Sodium Injection Sales by Type (2022-2027) & (K Units)
Table 78. Asia Pacific Enoxaparin Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 79. Asia Pacific Enoxaparin Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 80. Asia Pacific Enoxaparin Sodium Injection Sales by Application (2016-2021) & (K Units)
Table 81. Asia Pacific Enoxaparin Sodium Injection Sales by Application (2022-2027) & (K Units)
Table 82. Asia Pacific Enoxaparin Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 83. Asia Pacific Enoxaparin Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 84. Asia Pacific Enoxaparin Sodium Injection Sales by Region (2016-2021) & (K Units)
Table 85. Asia Pacific Enoxaparin Sodium Injection Sales by Region (2022-2027) & (K Units)
Table 86. Asia Pacific Enoxaparin Sodium Injection Revenue by Region (2016-2021) & (US$ Million)
Table 87. Asia Pacific Enoxaparin Sodium Injection Revenue by Region (2022-2027) & (US$ Million)
Table 88. Latin America Enoxaparin Sodium Injection Sales by Type (2016-2021) & (K Units)
Table 89. Latin America Enoxaparin Sodium Injection Sales by Type (2022-2027) & (K Units)
Table 90. Latin America Enoxaparin Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 91. Latin America Enoxaparin Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 92. Latin America Enoxaparin Sodium Injection Sales by Application (2016-2021) & (K Units)
Table 93. Latin America Enoxaparin Sodium Injection Sales by Application (2022-2027) & (K Units)
Table 94. Latin America Enoxaparin Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 95. Latin America Enoxaparin Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 96. Latin America Enoxaparin Sodium Injection Sales by Country (2016-2021) & (K Units)
Table 97. Latin America Enoxaparin Sodium Injection Sales by Country (2022-2027) & (K Units)
Table 98. Latin America Enoxaparin Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 99. Latin America Enoxaparin Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 100. Middle East and Africa Enoxaparin Sodium Injection Sales by Type (2016-2021) & (K Units)
Table 101. Middle East and Africa Enoxaparin Sodium Injection Sales by Type (2022-2027) & (K Units)
Table 102. Middle East and Africa Enoxaparin Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 103. Middle East and Africa Enoxaparin Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 104. Middle East and Africa Enoxaparin Sodium Injection Sales by Application (2016-2021) & (K Units)
Table 105. Middle East and Africa Enoxaparin Sodium Injection Sales by Application (2022-2027) & (K Units)
Table 106. Middle East and Africa Enoxaparin Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Enoxaparin Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 108. Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2016-2021) & (K Units)
Table 109. Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2022-2027) & (K Units)
Table 110. Middle East and Africa Enoxaparin Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 111. Middle East and Africa Enoxaparin Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 112. Sanofi Corporation Information
Table 113. Sanofi Description and Major Businesses
Table 114. Sanofi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Sanofi Enoxaparin Sodium Injection Product
Table 116. Sanofi Recent Developments
Table 117. Fresenius Kabi Corporation Information
Table 118. Fresenius Kabi Description and Major Businesses
Table 119. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Fresenius Kabi Enoxaparin Sodium Injection Product
Table 121. Fresenius Kabi Recent Developments
Table 122. Rovi Corporation Information
Table 123. Rovi Description and Major Businesses
Table 124. Rovi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Rovi Enoxaparin Sodium Injection Product
Table 126. Rovi Recent Developments
Table 127. Amphastar Corporation Information
Table 128. Amphastar Description and Major Businesses
Table 129. Amphastar Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Amphastar Enoxaparin Sodium Injection Product
Table 131. Amphastar Recent Developments
Table 132. Teva Corporation Information
Table 133. Teva Description and Major Businesses
Table 134. Teva Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Teva Enoxaparin Sodium Injection Product
Table 136. Teva Recent Developments
Table 137. Nanjing King-friend Corporation Information
Table 138. Nanjing King-friend Description and Major Businesses
Table 139. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Nanjing King-friend Enoxaparin Sodium Injection Product
Table 141. Nanjing King-friend Recent Developments
Table 142. Techdow (Hepalink) Corporation Information
Table 143. Techdow (Hepalink) Description and Major Businesses
Table 144. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Techdow (Hepalink) Enoxaparin Sodium Injection Product
Table 146. Techdow (Hepalink) Recent Developments
Table 147. Sandoz Corporation Information
Table 148. Sandoz Description and Major Businesses
Table 149. Sandoz Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Sandoz Enoxaparin Sodium Injection Product
Table 151. Sandoz Recent Developments
Table 152. Apotex Corporation Information
Table 153. Apotex Description and Major Businesses
Table 154. Apotex Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Apotex Enoxaparin Sodium Injection Product
Table 156. Apotex Recent Developments
Table 157. Cipla Corporation Information
Table 158. Cipla Description and Major Businesses
Table 159. Cipla Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. Cipla Enoxaparin Sodium Injection Product
Table 161. Cipla Recent Developments
Table 162. Taj Pharma Corporation Information
Table 163. Taj Pharma Description and Major Businesses
Table 164. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. Taj Pharma Enoxaparin Sodium Injection Product
Table 166. Taj Pharma Recent Developments
Table 167. Hangzhou Jiuyuan Gene Engineering Corporation Information
Table 168. Hangzhou Jiuyuan Gene Engineering Description and Major Businesses
Table 169. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product
Table 171. Hangzhou Jiuyuan Gene Engineering Recent Developments
Table 172. Chengdu Baiyu Pharmaceutical Corporation Information
Table 173. Chengdu Baiyu Pharmaceutical Description and Major Businesses
Table 174. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product
Table 176. Chengdu Baiyu Pharmaceutical Recent Developments
Table 177. Hebei Changshan Biochemical Pharmaceutical Corporation Information
Table 178. Hebei Changshan Biochemical Pharmaceutical Description and Major Businesses
Table 179. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 180. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product
Table 181. Hebei Changshan Biochemical Pharmaceutical Recent Developments
Table 182. Changzhou Qianhong Bio-pharma Corporation Information
Table 183. Changzhou Qianhong Bio-pharma Description and Major Businesses
Table 184. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 185. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product
Table 186. Changzhou Qianhong Bio-pharma Recent Developments
Table 187. Beijing SL Pharmaceutical Corporation Information
Table 188. Beijing SL Pharmaceutical Description and Major Businesses
Table 189. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 190. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product
Table 191. Beijing SL Pharmaceutical Recent Developments
Table 192. Suzhou Erye Pharmaceutical Corporation Information
Table 193. Suzhou Erye Pharmaceutical Description and Major Businesses
Table 194. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 195. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product
Table 196. Suzhou Erye Pharmaceutical Recent Developments
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Enoxaparin Sodium Injection Distributors List
Table 200. Enoxaparin Sodium Injection Customers List
Table 201. Enoxaparin Sodium Injection Market Trends
Table 202. Enoxaparin Sodium Injection Market Drivers
Table 203. Enoxaparin Sodium Injection Market Challenges
Table 204. Enoxaparin Sodium Injection Market Restraints
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Enoxaparin Sodium Injection Product Picture
Figure 2. Global Enoxaparin Sodium Injection Market Share by Type in 2020 & 2027
Figure 3. 20 mg/0.2mL Product Picture
Figure 4. 30 mg/0.3mL Product Picture
Figure 5. 40 mg/0.4mL Product Picture
Figure 6. 60 mg/0.6mL Product Picture
Figure 7. 80 mg/0.8mL Product Picture
Figure 8. 100 mg/1mL Product Picture
Figure 9. 120 mg/0.8mL Product Picture
Figure 10. 150 mg/1mL Product Picture
Figure 11. 300mg/3mL Product Picture
Figure 12. Global Enoxaparin Sodium Injection Market Share by Application in 2020 & 2027
Figure 13. Hospital
Figure 14. Clinic
Figure 15. Others
Figure 16. Enoxaparin Sodium Injection Report Years Considered
Figure 17. Global Enoxaparin Sodium Injection Sales 2016-2027 (K Units)
Figure 18. Global Enoxaparin Sodium Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Enoxaparin Sodium Injection Revenue 2016-2027 (US$ Million)
Figure 20. Global Enoxaparin Sodium Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Enoxaparin Sodium Injection Sales Market Share by Region (2016-2021)
Figure 22. Global Enoxaparin Sodium Injection Sales Market Share by Region (2022-2027)
Figure 23. North America Enoxaparin Sodium Injection Sales YoY (2016-2027) & (K Units)
Figure 24. North America Enoxaparin Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Enoxaparin Sodium Injection Sales YoY (2016-2027) & (K Units)
Figure 26. Europe Enoxaparin Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Enoxaparin Sodium Injection Sales YoY (2016-2027) & (K Units)
Figure 28. Asia-Pacific Enoxaparin Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Enoxaparin Sodium Injection Sales YoY (2016-2027) & (K Units)
Figure 30. Latin America Enoxaparin Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Enoxaparin Sodium Injection Sales YoY (2016-2027) & (K Units)
Figure 32. Middle East & Africa Enoxaparin Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Enoxaparin Sodium Injection Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Enoxaparin Sodium Injection Revenue in 2020
Figure 35. Enoxaparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
Figure 37. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 38. Global Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
Figure 39. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 40. North America Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
Figure 41. North America Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 42. North America Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
Figure 43. North America Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 44. North America Enoxaparin Sodium Injection Sales Share by Country (2016-2027)
Figure 45. North America Enoxaparin Sodium Injection Revenue Share by Country (2016-2027)
Figure 46. United States Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
Figure 49. Europe Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 50. Europe Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
Figure 51. Europe Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 52. Europe Enoxaparin Sodium Injection Sales Share by Country (2016-2027)
Figure 53. Europe Enoxaparin Sodium Injection Revenue Share by Country (2016-2027)
Figure 54. Germany Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 55. France Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Enoxaparin Sodium Injection Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Enoxaparin Sodium Injection Revenue Share by Region (2016-2027)
Figure 65. China Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 68. India Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
Figure 75. Latin America Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
Figure 77. Latin America Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Enoxaparin Sodium Injection Sales Share by Country (2016-2027)
Figure 79. Latin America Enoxaparin Sodium Injection Revenue Share by Country (2016-2027)
Figure 80. Mexico Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 83. Colombia Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 84. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Enoxaparin Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 86. Middle East and Africa Enoxaparin Sodium Injection Sales Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Enoxaparin Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Enoxaparin Sodium Injection Sales Share by Country (2016-2027)
Figure 89. Middle East and Africa Enoxaparin Sodium Injection Revenue Share by Country (2016-2027)
Figure 90. Turkey Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 91. Saudi Arabia Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 92. UAE Enoxaparin Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 93. Enoxaparin Sodium Injection Value Chain
Figure 94. Enoxaparin Sodium Injection Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

---